- Health Canada issued warnings regarding products sold in the country.
- Health Canada found multiple deficiencies at Grifols sites, leading to a partnership established for collecting plasma for medicine.
Grifols, Canadian Blood Services, and Health Canada are working on a framework for sustainable plasma collection.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Grifols, Canadian Blood Services, and Health Canada are working on a framework for sustainable plasma collection.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Grifols
Spanish pharmaceutical company
Nothing else this week.
-
Canadian Blood Services
Canadian charitable organization and national blood bank
Nothing else this week.
-
Health Canada
Department of the Canadian Government that oversees public health
Related events
- Grifols, a plasma therapeutic company, operates in the US, Spain, and Canada, and MarketBeat is reporting on analyst recommendations for the company.
- Ground zero for commercial paid plasma collection in Saskatchewan, facing scrutiny over standards.
- Three major organizations are facing a shared global challenge regarding the strain on worldwide blood supply systems.
- A global blood crisis is underway, prompting international cooperation and affecting multiple nations, including issues in England.